Trying to determine the differences between a DO and MD? Wondering which option is better for you before you finalize your school list? Inspira Advantage is here to help: you’re invited to join our “Deciding Between a DO vs. MD” webinar!
Our expert admissions consultants will explain what you need to know about DO versus MD programs, including:
Are you ready to learn what program is best for you and forge your path to success? Register today to claim your seat and gain more clarity on what’s best for you.
Nakia is currently a senior General Surgery Resident at New York-Presbyterian/Queens - Weill Cornell. She obtained her Bachelor's in Science at UCLA and graduated with honors majoring in Physiological Sciences and a minor in Global Studies. Before medical school, she pursued a Master's of Science at Keck Graduate Institute with an emphasis on biotechnology, focusing on device and diagnostic development. Nakia worked with many biotech/pharmaceutical companies on projects involving clinical applicability and the impact of therapeutic options. She completed her medical school education at Touro College of Medicine as a member of the Sigma Sigma Phi National Honors Society, graduating in the top 10% of her class. Nakia also has a vested interest in global medicine and started a new Global Brigades chapter in her graduate program with medical trips to Central America. Throughout this journey, she has been heavily involved in research, presenting at national conferences such as CHEST and publishing manuscripts.
Andrew is a fourth-year medical student at the Icahn School of Medicine at Mount Sinai pursuing a career in Anesthesiology. He has a startup valued at $12 million which focuses on providing affordable vision care across the US, has >20 peer-reviewed publications, and is looking to continue to help others in their medical careers. Originally from the greater Pittsburgh area, Andrew went to public school all his life and attended the University of Pittsburgh, where he majored in computational chemistry with a focus in biology. He conducted research through the Department of Biomedical Informatics, where he published a paper in Scientific Reports on long non-coding RNA SNHG7 and its impact on breast cancer. He graduated in three years from Pitt and went straight to medical school at the Icahn School of Medicine at Mount Sinai. During his first year there, he joined multiple research labs focusing on large-data analysis and machine learning. He also co-founded Retina Technologies Inc., a company aimed to disrupt vision care by leveraging virtual reality, retinal imaging, and machine learning onto a portable platform to provide affordable, accessible, and accurate vision screening across the country.